SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040469
Filing Date
2019-11-05
Accepted
2019-11-05 17:03:33
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20190930.htm 10-Q 1912734
2 EX-10.2 tcon-ex102_224.htm EX-10.2 28455
3 EX-31.1 tcon-ex311_7.htm EX-31.1 9270
4 EX-32.1 tcon-ex321_6.htm EX-32.1 5625
  Complete submission text file 0001564590-19-040469.txt   7658041

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tcon-20190930.xml EX-101.INS 1945529
6 XBRL TAXONOMY EXTENSION SCHEMA tcon-20190930.xsd EX-101.SCH 56856
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20190930_cal.xml EX-101.CAL 40936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20190930_def.xml EX-101.DEF 158976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20190930_lab.xml EX-101.LAB 382874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20190930_pre.xml EX-101.PRE 276777
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 191194163
SIC: 2836 Biological Products, (No Diagnostic Substances)